A Study to Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete Resection

NCT03980314 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

261

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Nivolumab

Sponsor

Bristol-Myers Squibb